230 related articles for article (PubMed ID: 17527041)
1. Interleukin-6-producing giant cell carcinoma of the lung with multicentric Castleman's disease-like presentation.
Higashikuni Y; Mori M; Kino H
Intern Med; 2007; 46(10):669-73. PubMed ID: 17527041
[TBL] [Abstract][Full Text] [Related]
2. A case of IgG4-related lung disease associated with multicentric Castleman's disease and lung cancer.
Ikari J; Kojima M; Tomita K; Nakamura T; Toyoda F; Otsuki Y; Shimizu S; Kobayashi H; Nakamura H
Intern Med; 2010; 49(13):1287-91. PubMed ID: 20606361
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
4. A case of multicentric Castleman's disease demonstrating severe eosinophilia and enhanced production of interleukin-5.
Ishii T; Tatekawa T; Koseto M; Ishii M; Kobayashi H; Koike M; Fujii T; Saeki Y
Eur J Haematol; 2003 Feb; 70(2):115-8. PubMed ID: 12581193
[TBL] [Abstract][Full Text] [Related]
5. Multicentric Castleman disease mimicking IgG4-related disease: A case report.
Izumi Y; Takeshita H; Moriwaki Y; Hisatomi K; Matsuda M; Yamashita N; Kawahara C; Shigemitsu Y; Iwanaga N; Kawakami A; Kurohama H; Niino D; Ito M; Migita K
Mod Rheumatol; 2017 Jan; 27(1):174-177. PubMed ID: 25528859
[TBL] [Abstract][Full Text] [Related]
6. IL-6 expression helps distinguish Castleman's disease from IgG4-related disease in the lung.
Kinugawa Y; Uehara T; Iwaya M; Asaka S; Kobayashi S; Nakajima T; Komatsu M; Yasuo M; Yamamoto H; Ota H
BMC Pulm Med; 2021 Jul; 21(1):219. PubMed ID: 34246246
[TBL] [Abstract][Full Text] [Related]
7. IL-6-positive classical Hodgkin's lymphoma co-occurring with plasma cell type of Castleman's disease: report of a case.
Momoi A; Kojima M; Sakai T; Ajiro J; Isahai N; Nagai K; Aoki S
Int J Hematol; 2013 Feb; 97(2):275-9. PubMed ID: 23359301
[TBL] [Abstract][Full Text] [Related]
8. Multicentric Castleman's disease in human immunodeficiency virus infection: two case reports.
Caroline Ribeiro Sales A; Romão de Souza Junior V; Iglis de Oliveira M; Azevedo Braga Albuquerque C; de Barros Campelo Júnior E; Sérgio Ramos de Araújo P
J Med Case Rep; 2018 May; 12(1):117. PubMed ID: 29728131
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6-producing Intravascular Large B-cell Lymphoma with Lymphadenopathy Mimicking the Histology of Multicentric Castleman Disease.
Shiroshita K; Kikuchi T; Okayama M; Kasahara H; Kamiya T; Shimizu T; Kurose N; Masaki Y; Okamoto S
Intern Med; 2020 Dec; 59(23):3061-3065. PubMed ID: 32759587
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease.
Nishi J; Arimura K; Utsunomiya A; Yonezawa S; Kawakami K; Maeno N; Ijichi O; Ikarimoto N; Nakata M; Kitajima I; Fukushige T; Takamatsu H; Miyata K; Maruyama I
Br J Haematol; 1999 Mar; 104(3):482-5. PubMed ID: 10086783
[TBL] [Abstract][Full Text] [Related]
11. Overlap of IgG4-related Disease and Multicentric Castleman's Disease in a Patient with Skin Lesions.
Mochizuki H; Kato M; Higuchi T; Koyamada R; Arai S; Okada S; Eto H
Intern Med; 2017; 56(9):1095-1099. PubMed ID: 28458319
[TBL] [Abstract][Full Text] [Related]
12. A transitional variant of Castleman's disease presenting as a chylous pleural effusion.
Ten Hoor T; Hewan-Lowe K; Miller JI; Moss M
Chest; 1999 Jan; 115(1):285-8. PubMed ID: 9925102
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hyalinizing granuloma with Castleman's disease.
Atagi S; Sakatani M; Akira M; Yamamoto S; Ueda E
Intern Med; 1994 Nov; 33(11):689-91. PubMed ID: 7849383
[TBL] [Abstract][Full Text] [Related]
14. Multicentric Castleman's disease in association with a solitary plasmacytoma: a case report.
Gould SJ; Diss T; Isaacson PG
Histopathology; 1990 Aug; 17(2):135-40. PubMed ID: 2227838
[TBL] [Abstract][Full Text] [Related]
15. [A case of multicentric Castleman's disease with pulmonary involvement].
Morise M; Shimomoto H; Honda T; Mori Y
Nihon Kokyuki Gakkai Zasshi; 2003 Jan; 41(1):59-65. PubMed ID: 12693008
[TBL] [Abstract][Full Text] [Related]
16. Increased interleukin-6 (IL-6) production in a young child with clinical and pathologic features of multicentric Castleman's disease.
Kinney MC; Hummell DS; Villiger PM; Hourigan A; Rollins-Smith L; Glick AD; Lawton AR
J Clin Immunol; 1994 Nov; 14(6):382-90. PubMed ID: 7883866
[TBL] [Abstract][Full Text] [Related]
17. [Multicentric Castleman's disease (MCD): recent knowledge of its pathogenesis].
Higashibara M; Horie R; Yoneyama A; Mori S
Rinsho Ketsueki; 1992 Nov; 33(11):1649-60. PubMed ID: 1469779
[No Abstract] [Full Text] [Related]
18. Generalized lymphadenopathy with morphologic features of Castleman's disease in an HIV-positive man.
Lowenthal DA; Filippa DA; Richardson ME; Bertoni M; Straus DJ
Cancer; 1987 Nov; 60(10):2454-8. PubMed ID: 3478119
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice.
Screpanti I; Musiani P; Bellavia D; Cappelletti M; Aiello FB; Maroder M; Frati L; Modesti A; Gulino A; Poli V
J Exp Med; 1996 Oct; 184(4):1561-6. PubMed ID: 8879230
[TBL] [Abstract][Full Text] [Related]
20. Osteosarcoma Manifesting Systemic Inflammation and Histological Features Mimicking Plasma Cell-type Castleman Disease.
Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Doai M; Matoba M; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Mizumaki H; Yamaguchi M; Masaki Y
Intern Med; 2019 Sep; 58(17):2555-2560. PubMed ID: 31178507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
